O'Donnell P, Dong C, Murthy V, Asgharnejad M, et al. The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. Neuropsychopharmacology 2023 Mar 16. doi: 10.1038/s41386-023-01560.
PMID: 36928351